Reported profit rose to EUR 109 million from EUR 91 million in the prior year. Tagliabue attributed part of the change in the tax line to a lower effective tax rate of 22% (from 30% last year), citing non-taxable income in 2025 related to the remeasurement of put option liabilities, “mainly the one on the remaining 8% stake on Thom Browne.”The group posted a 67.5% gross margin and adjusted EBIT of EUR 163 million , which included EUR 10 million of provisions tied to expected losses on trade receivables rela ...

Core Insights - Carl Zeiss Meditec reported a weaker-than-expected start to fiscal 2025/26, with management citing currency headwinds, an unfavorable product mix, and challenges in China and the U.S. as key drivers of lower revenue and sharply reduced profitability in the first quarter [4] Order Intake and Backlog - Order intake was EUR 471 million, down 9.7% year over year (down 6.9% currency-adjusted), with management linking this decline to a strong year-end close in September 2025. The order backlog increased to EUR 405 million, slightly above the level at the end of the prior fiscal year [1] Revenue Performance - Revenue totaled EUR 467 million for the quarter, down 4.8% year over year. On a constant currency basis, revenue fell 2.1%, with management attributing the largest currency impact to the U.S. dollar and Chinese yuan, quantifying total FX headwinds at about EUR 20 million for the period [3][7] Segment Analysis - In the Ophthalmology segment, revenue was EUR 357 million, down 5.1% year over year (down 2.4% currency-adjusted). The segment faced challenges due to lost bifocal intraocular lens (IOL) sales in China and timing effects [9] - Microsurgery revenue was just under EUR 110 million, down 3.7% year over year (down 0.9% currency-adjusted), attributed to a pull-forward from strong deliveries into the prior fiscal year-end and slower deliveries of neurosurgical microscopes [12] Profitability Metrics - EBITDA plunged to EUR 68.8 million, with an EBITDA margin collapsing to 1.7% from 7.2% a year earlier, attributed to adverse product mix, FX impacts, and negative operating leverage [7][8] Regional Performance - Revenue in the Americas fell approximately 13% year over year, attributed to a softer investment climate and tariff-related price increases. EMEA revenue was described as largely stable, while APAC revenue was down 3% year over year, with mixed performance across the region [5][14] Guidance and Future Outlook - Management suspended full-year guidance due to uncertainties related to the China bifocal IOL VBP impact, inventory uncertainty, and weaker U.S. equipment demand. A successor IOL registration is expected around March, with a tender due in April/May [6][15] - New guidance will be provided no later than the half-year results, with management acknowledging elevated near-term volatility but expecting continued momentum for certain product rollouts [17]

Packaged food company Thai Union lowers its sales growth outlook, citing nagging macroeconomic factors including US tariffs and currency headwinds. https://t.co/9vuIbLremp ...

Core Insights - Puig expects to achieve full-year growth guidance of 6 percent to 8 percent for 2025, surpassing consensus expectations, driven by strong third-quarter sales [1] - The company's sales for Q3 reached 1.3 billion euros, reflecting a 3.2 percent increase on a reported basis and a 6.1 percent increase in like-for-like terms, outperforming the global premium beauty market [1][3] Sales Performance - In Q3, Puig's Fragrance and Fashion division saw a 2.8 percent organic sales increase, while Makeup sales surged by 18.8 percent, largely due to Charlotte Tilbury's performance on Amazon [3] - Skin Care sales grew by 10.5 percent, contributing to the overall positive sales trend [3] Year-to-Date Performance - For the first nine months of 2025, Puig's sales totaled 3.6 billion euros, marking a 4.9 percent increase on a reported basis and a 7 percent increase in like-for-like terms [3] Geographic Performance - All geographic regions contributed positively to sales, with the Europe, Middle East, and Africa zone accounting for 53 percent of net sales, reaching 1.9 billion euros and a 3.9 percent like-for-like increase [4] - The Americas represented 37 percent of net sales, totaling 1.33 billion euros with a 7.8 percent increase [5] - The Asia-Pacific region outperformed with sales of 367.6 million euros, achieving 23 percent organic growth, making it Puig's fastest-growing region [6]

Core Insights - The Coca-Cola Company (KO) is expected to report third-quarter 2025 earnings on October 21, with anticipated year-over-year growth in both revenue and earnings [1][9]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for revenues is $12.4 billion, reflecting a 4.9% increase from the previous year [2]. - The consensus estimate for earnings is 78 cents per share, indicating a 1.3% growth from the prior-year quarter [2]. - The earnings estimate has increased by a penny in the last 30 days [2]. Performance Trends - Coca-Cola has shown consistent earnings outcomes, with a trailing four-quarter earnings surprise of 4.9% on average [3]. - The company has a Zacks Rank of 4 (Sell) and an Earnings ESP of -0.38%, indicating uncertainty regarding an earnings beat this quarter [4][3]. Market Challenges - The company is facing volume pressure in key markets, particularly in North America and Europe, due to changing consumer behavior and economic challenges [5]. - Low-income consumers are becoming more value-conscious amid inflation, leading to soft volumes [5]. - Currency headwinds are expected to impact revenues and earnings per share, with a 1% revenue headwind and a 5-6% EPS headwind anticipated [7][9]. Profitability Pressures - Rising tax burdens and elevated interest expenses are expected to pressure profitability, despite strong operational performance [8]. - The combination of higher taxes and financing costs could hinder net income growth amid ongoing volume softness [8]. Strategic Strengths - Coca-Cola's diverse brand portfolio and strategic investments are expected to support revenue growth, with a forecasted 6.9% year-over-year increase in organic revenues driven by an 8.2% rise in price/mix [12][10]. - The company has seen significant growth in e-commerce, with digital investments likely boosting third-quarter revenues [13]. Stock Performance and Valuation - KO shares have increased by 7.8% year to date, outperforming the broader industry and the Consumer Staples sector [14]. - The stock trades at a forward 12-month P/E multiple of 21.21X, above the industry average of 17.76X, indicating a potentially stretched valuation [18][19]. Long-term Outlook - Coca-Cola commands over 40% of the global non-alcoholic beverage market, supported by a strong market presence and innovation focus [20]. - Despite short-term challenges such as inflation and currency fluctuations, the company is well-positioned for sustained long-term growth [21]. - The upcoming earnings report is expected to reinforce Coca-Cola's resilience and growth outlook, making it a compelling long-term investment [22].